SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron who wrote (713)4/22/1999 11:56:00 AM
From: yosi s  Read Replies (3) of 1386
 
Tamoxiphen

They did not start phase 1 study yet.
How long it will take ?.
Depends on how much money you want to spend on each phase.
But they can get a a partner sooner and that will move things faster.

Also the fact that recently George Fink MD Phd joined Pharmos signify to me that they plan to move on and advance their research. And that the products have a big potential.

But first we got to see.

Alrex and Lotemax sales growth. Le Tobra.
HU 211 partner. etc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News